JPMorgan is backing four pharma and CRDMO stocks, but one name stands out with nearly 25% potential upside. Here’s what…
Cipla partners with Sino Biopharmaceutical’s subsidiary to license and supply innovative breast cancer drug TQB2102, targeting HER2-low cancers across India,…
Cipla’s US subsidiary InvaGen’s manufacturing plant received a Voluntary Action Indicated classification from the USFDA after inspection, noting observations without…
On February 6, 2001, Cipla chairman Yusuf Hamied shocked the world by offering a three-drug AIDS cocktail for $350 a…
Cipla and Dr. Reddy’s entered FY27 on different trajectories. While Cipla posted record quarterly revenue backed by respiratory growth, Dr.…
Cipla Q1FY27 revenue rose 2.3% and India sales hit a record. The company expects sequential growth in North America supported…
Track pharma stocks as Trump’s phased US tariff plan hits sentiment, though analysts say India’s cost edge may cushion generic…
Track Q1FY27 results this week as 270 firms, including Infosys, Nestle India, Bajaj Auto, NTPC and Paytm, report earnings.
Pharma stocks including Abbott India, Sun Pharma, Torrent Pharma, Cipla and Divi’s Laboratories are in focus after announcing FY26 dividends…
Nomura sees up to 26% upside in Cipla, Dr Reddy’s Lab, and Crompton Greaves—discover why these stocks are top picks…
Grasim to get Rs 3,970 crore from UltraTech dividend; Jefferies sees 15% upside—track Grasim’s moves for investment opportunities!
Cipla surges 8% despite 55% profit drop as brokerages turn bullish—explore if this rally signals a buying opportunity!
Dalal Street witnessed sharp stock-specific action as Cipla, Adani Enterprises, MTAR Technologies and Oil India rallied after earnings and deals,…
Sensex, Nifty today, May 14: Sensex jumps nearly 800 points, Nifty closes strong at 23,700; explore top gainers and market…
Cipla Q4 profit plunges 55% to Rs 555 crore; company announces Rs 13 dividend. Learn more about Cipla’s financial results!
Sensex, Nifty updates today, May 13: Markets rebound as Sensex surges over 500 points and Nifty climbs above 23,500; track…
Over 400 firms, including Cipla, Airtel & Tata Steel, to unveil Q4 results this week. Track key announcements and dividend…
JM Financial warns of a widening gap between Nifty valuations and earnings as 66% of companies see EPS cuts. Here…